8/29/24 18:43 | 8/27/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | | S | -8 | 1.35 | 0 | -6 | -1 | 759 | D | | | | | | | | | | | | | | |
2/5/24 20:50 | 2/2/24 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | | S | -87 | 1.37 | 0 | -64 | -8 | 745 | D | | | | | | | | | | | | | | |
8/30/23 16:21 | 8/28/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | | S | -11 | 1.26 | 0 | -9 | -1 | 789 | D | | | | | | | | | | | | | | |
2/6/23 16:15 | 2/3/23 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S | -22 | 1.81 | 0 | -12 | -2 | 798 | D | | | | | | | | | | | | | | |
12/29/21 18:26 | 12/27/21 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.d | 47 | 5.90 | 0 | 8 | 6 | 144 | D | | | | | | | | | | | | | | |
12/29/21 18:26 | 12/27/21 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.d | -117 | 14.58 | 0 | -8 | -5 | 144 | D | | | | | | | | | | | | | | |
11/5/20 19:00 | 11/3/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.dm | 56 | 5.90 | 0 | 10 | 17 | 66 | D | | | | | | | | | | | | | | |
11/5/20 19:00 | 11/3/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.dm | -137 | 14.39 | 0 | -10 | -13 | 66 | D | | | | | | | | | | | | | | |
10/27/20 17:32 | 10/23/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.d | 0 | 5.90 | 0 | 0 | 0 | 66 | D | | | | | | | | | | | | | | |
10/27/20 17:32 | 10/23/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.d | 0 | 14.25 | 0 | 0 | 0 | 66 | D | | | | | | | | | | | | | | |
10/15/20 20:24 | 10/13/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.dm | 85 | 5.90 | 0 | 14 | 28 | 66 | D | | | | | | | | | | | | | | |
10/15/20 20:24 | 10/13/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.dm | -207 | 14.28 | 0 | -14 | -18 | 66 | D | | | | | | | | | | | | | | |
9/10/20 21:51 | 9/8/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.d | 5 | 5.90 | 0 | 1 | 1 | 66 | D | | | | | | | | | | | | | | |
9/10/20 21:51 | 9/8/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.d | -11 | 14.25 | 0 | -1 | -1 | 66 | D | | | | | | | | | | | | | | |
7/9/20 18:48 | 7/7/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | M.dm | 18 | 5.90 | 0 | 3 | 5 | 66 | D | | | | | | | | | | | | | | |
7/9/20 18:48 | 7/7/20 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | CEO,P | S.dm | -44 | 14.29 | 0 | -3 | -4 | 66 | D | | | | | | | | | | | | | | |
7/6/18 21:41 | 7/5/18 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | See Rema | M.dm | 28 | 5.90 | 0 | 5 | 8 | 66 | D | | | | | | | | | | | | | | |
7/6/18 21:41 | 7/5/18 | SPRO | Spero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | DO | See Rema | S.dm | -82 | 17.63 | 0 | -5 | -7 | 66 | D | | | | | | | | | | | | | | |